Endometriosis Therapeutics Market to Grow with a CAGR of 6.88% through 2030
Rising prevalence of
endometriosis and increasing awareness and early diagnosis are factors driving
the Global Endometriosis Therapeutics Market in the forecast period 2026-2030.
According to the
TechSci Research report, “Endometriosis Therapeutics Market - Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Endometriosis Therapeutics Market stood at USD 1.71 Billion in 2024
and is anticipated to grow with a CAGR of 6.88% through 2030. The growing prevalence of endometriosis
globally is a major driver of the therapeutics market. According to health
authorities, approximately 10% of women in their reproductive years are
affected by this condition, with many cases remaining undiagnosed. The
increasing recognition of endometriosis as a significant public health concern
is fueling demand for effective treatment options, ranging from hormonal
therapies to non-hormonal drugs. This rising patient pool directly contributes
to the market’s expansion.
Awareness
campaigns by healthcare organizations, patient advocacy groups, and government
bodies are enhancing understanding of endometriosis. Historically, delayed
diagnosis has been a challenge, with women often waiting years before receiving
proper treatment. However, improved education among both patients and
healthcare providers is enabling earlier recognition of symptoms and faster
access to therapeutic interventions. This trend supports higher demand for
innovative therapies and broadens the adoption of available treatment options.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global
Endometriosis Therapeutics Market”
Pharmaceutical
companies are investing heavily in research and development to introduce novel
therapeutics that offer better efficacy and fewer side effects compared to
conventional treatments. The pipeline includes next-generation hormonal agents,
non-hormonal therapies, and biologics that specifically target the underlying
mechanisms of endometriosis. Continuous innovation not only enhances treatment
outcomes but also creates opportunities for market differentiation, driving
competition and growth in the sector.
The Global Endometriosis
Therapeutics Market is segmented into Endometriosis Type, Diagnostic Method, Treatment Method, Drug Category, Distribution Channel, End
User, regional distribution, and company.
Based
on the treatment method, the Hormonal Therapy segment is dominating the global Endometriosis
Therapeutics Market in 2024, due to several key factors. Hormonal therapies,
such as oral contraceptives, progestins, and gonadotropin-releasing hormone
(GnRH) agonists, effectively manage endometriosis symptoms by regulating
estrogen levels and reducing menstrual bleeding and pelvic pain. These
treatments are widely recommended by healthcare professionals as first-line
therapy due to their non-invasive nature and proven efficacy. Additionally,
increasing awareness of endometriosis and early diagnosis has expanded the
patient base seeking long-term symptom management, further driving demand for
hormonal therapies. Cost-effectiveness and availability in both developed and
emerging regions also contribute to this segment’s market dominance.
The
Asia Pacific is the fastest-growing region in the Global Endometriosis
Therapeutics Market in 2024. Rising awareness of endometriosis and increasing
initiatives for early diagnosis are driving higher patient detection rates.
Expanding healthcare infrastructure, greater accessibility to advanced
treatments, and increasing availability of innovative therapeutics contribute
to market growth. Moreover, a growing female population in reproductive age and
rising prevalence of endometriosis further boost demand. Supportive government
policies, coupled with increasing investment from global pharmaceutical
companies in clinical trials and market expansion, are accelerating the
adoption of endometriosis therapies across the region.
Major companies
operating in the Global Endometriosis Therapeutics Market are:
- The Abbott
Laboratories, Inc.
- AbbVie,
Inc.
- Bayer
AG
- Pfizer,
Inc.
- Ipsen
SA
- Evotec
SE
- Myovant
Sciences Ltd.
- Philogen
S.p.A.
- Astellas
Pharma Inc.
- Orphagen
Pharmaceuticals, Inc.
Download Free Sample Report
Customers can
also request 10% free customization on this report
“Endometriosis is a leading cause of
infertility, which has positioned its treatment as an integral component of
reproductive healthcare. With the fertility treatment market growing globally,
the overlap between endometriosis care and assisted reproductive technologies
(ART) is creating additional demand for therapeutics. Patients seeking
fertility support are increasingly prescribed therapies that manage
endometriosis symptoms, thereby supporting better reproductive outcomes and
driving sales of related medications, “said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“ Endometriosis Therapeutics Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2020-2030F Segmented By Endometriosis
Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating
Endometriosis Therapeutics), By Diagnostic Method (Ultrasound, Pelvic
Examination, Laparoscopy, Magnetic Resonance Imaging, And Others), By Treatment
Method (Hormonal Therapy, And Pain Management), By Drug Category (Oral
Contraceptives, Progestins, NSAIDs, GnRH Analogues, And Others), By Diagnostics
Type (Pure Medical Imaging, And General Laboratory Use), By Distribution
Channel ( Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By
End-User, (Hospitals & Clinics, Ambulatory Care Center, And Others), By
Region and Competition ”, has evaluated the future growth
potential of Global Endometriosis
Therapeutics Market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the Global Endometriosis
Therapeutics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com